Showing results (461-470 of 624) with videos related to

Sort By:
Pageof 63
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)S Keating, T de Witte, S Suciu, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
Leukemia|January 1, 1991
Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsG Cimino, S Amadori, M C Cava, et al.
Plos One|December 5, 2014
Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in miceZachary B Smithline, Anna S Nikonova, Harvey H Hensley, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropeniaA Del Favero, F Menichetti, P Martino, et al.
Haematologica|December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of RomeA M Testi, M L Moleti, F Giona, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
British Journal of Haematology|May 1, 1981
Factor VII deficiency: immunological characterization of genetic variants and detection of carriersG Mariani, M G Mazzucconi, J Hermans, et al.
Pageof 63